PMID: 42299163

Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System.

Makhmutov Alisher, Qureshi Faisal

Cureus · 2026

Vol. 18, Issue 5, pp. e108868

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.